Qutaiba Amir Tawfic
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Qutaiba Amir Tawfic has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
Ali S. Faris
Department of Anesthesiology The Ottawa Hospital University of Ottawa Ottawa ON Canada
2 shared publications- Denise Kreutzwiser
Pharmacy Department and Pain Management Program, St. Joseph’s Health Care London, London, Ontario, Canada
2 shared publications Kevin Armstrong
Western University, London Health Science Centre, University Hospital, Department of Anesthesia and Perioperative Medicine, Complex Pain Management Program, London, Canada
2 shared publicationsMooyad A. Ahmed
2 shared publicationsRajini Kausalya
2 shared publicationsAhmed K Mohammed
1 shared publication
Latest Publications
- Open Access
- 3 February 2021
- Published by Elsevier in Brazilian Journal of Anesthesiology (English Edition)
- Vol. 71 (2) , 116-122
A survey of acute pain service in Canadian teaching hospitals
- 3 February 2021
- Published by Elsevier in Brazilian Journal of Anesthesiology (English Edition)
- Vol. 71 (2) , 116-122
Open AccessA survey of acute pain service in Canadian teaching hospitals
- 20 June 2020
- Published by Springer Nature in CNS Drugs
- Vol. 34 (8) , 827-839
Methadone for Pain Management: A Pharmacotherapeutic Review
Methadone is increasingly being used for its analgesic properties. Despite the increasing popularity, many healthcare providers are not familiar with methadone’s complex pharmacology and best practices surrounding its use. The purpose of this narrative review article is to discuss the pharmacology of methadone, the evidence surrounding methadone’s use in acute pain management and both chronic cancer and non-cancer pain settings, as well as highlight pertinent safety, monitoring, and opioid rotation considerations. Methadone has a unique mechanism of action when compared with all other opioids and for this reason methadone has come to hold a niche role in the management of opioid-induced hyperalgesia and central sensitization. Understanding of the mechanisms of variability in methadone disposition and drug interactions has evolved over the years, with the latest evidence revealing that CYP 2B6 is the major determinant of methadone elimination and plays a key role in methadone-related drug interactions. From an acute pain perspective, most studies evaluating the use of intraoperative intravenous methadone have reported lower pain scores and post-operative opioid requirements. Oral methadone is predominantly used as a second-line opioid treatment for select chronic pain conditions. As a result, several oral morphine to oral methadone conversion ratios have been proposed, as have methods in which to rotate to methadone. From an efficacy standpoint, limited literature exists regarding the effectiveness of methadone in the chronic pain setting with most of the available efficacy data pertaining to methadone’s use in the treatment of cancer pain. Many of the prospective studies that exist feature low participant numbers. Few clinical trials investigating the role of methadone as an analgesic treatment are currently underway. The complicated pharmacokinetic properties of methadone and risks of harm associated with this drug highlight how critically important it is that healthcare providers understand these features before prescribing/dispensing methadone. Particular caution is required when converting patients from other opioids to methadone and for this reason only experienced healthcare providers should undertake such a task. Further randomized trials with larger sample sizes are needed to better define the effective and safe use of methadone for pain management.
- 20 June 2020
- Published by Springer Nature in CNS Drugs
- Vol. 34 (8) , 827-839
Methadone for Pain Management: A Pharmacotherapeutic Review
Methadone is increasingly being used for its analgesic properties. Despite the increasing popularity, many healthcare providers are not familiar with methadone’s complex pharmacology and best practices surrounding its use. The purpose of this narrative review article is to discuss the pharmacology of methadone, the evidence surrounding methadone’s use in acute pain management and both chronic cancer and non-cancer pain settings, as well as highlight pertinent safety, monitoring, and opioid rotation considerations. Methadone has a unique mechanism of action when compared with all other opioids and for this reason methadone has come to hold a niche role in the management of opioid-induced hyperalgesia and central sensitization. Understanding of the mechanisms of variability in methadone disposition and drug interactions has evolved over the years, with the latest evidence revealing that CYP 2B6 is the major determinant of methadone elimination and plays a key role in methadone-related drug interactions. From an acute pain perspective, most studies evaluating the use of intraoperative intravenous methadone have reported lower pain scores and post-operative opioid requirements. Oral methadone is predominantly used as a second-line opioid treatment for select chronic pain conditions. As a result, several oral morphine to oral methadone conversion ratios have been proposed, as have methods in which to rotate to methadone. From an efficacy standpoint, limited literature exists regarding the effectiveness of methadone in the chronic pain setting with most of the available efficacy data pertaining to methadone’s use in the treatment of cancer pain. Many of the prospective studies that exist feature low participant numbers. Few clinical trials investigating the role of methadone as an analgesic treatment are currently underway. The complicated pharmacokinetic properties of methadone and risks of harm associated with this drug highlight how critically important it is that healthcare providers understand these features before prescribing/dispensing methadone. Particular caution is required when converting patients from other opioids to methadone and for this reason only experienced healthcare providers should undertake such a task. Further randomized trials with larger sample sizes are needed to better define the effective and safe use of methadone for pain management.
- 2 March 2019
- Published by Springer Nature in CNS Drugs
- Vol. 33 (4) , 347-374
Expanding Role of NMDA Receptor Antagonists in the Management of Pain
Pain management is complex regardless of whether the pain is acute or chronic in nature or non-cancer or cancer related. In addition, relatively few pain pharmacotherapy options with adequate efficacy and safety data currently exist. Consequently, interest in the role of NMDA receptor antagonists as a pharmacological pain management strategy has surfaced. This narrative review provides an overview of the NMDA receptor and elaborates on the pharmacotherapeutic profile and pain management literature findings for the following NMDA receptor antagonists: ketamine, memantine, dextromethorphan, and magnesium. The literature on this topic is characterized by small studies, many of which exhibit methodological flaws. To date, ketamine is the most studied NMDA receptor antagonist for both acute and chronic pain management. Although further research about NMDA receptor antagonists for analgesia is needed and the optimal dosage/administration regimens for these drugs have yet to be determined, ketamine appears to hold the most promise and may be of particular value in the perioperative pain management realm.
- 2 March 2019
- Published by Springer Nature in CNS Drugs
- Vol. 33 (4) , 347-374
Expanding Role of NMDA Receptor Antagonists in the Management of Pain
Pain management is complex regardless of whether the pain is acute or chronic in nature or non-cancer or cancer related. In addition, relatively few pain pharmacotherapy options with adequate efficacy and safety data currently exist. Consequently, interest in the role of NMDA receptor antagonists as a pharmacological pain management strategy has surfaced. This narrative review provides an overview of the NMDA receptor and elaborates on the pharmacotherapeutic profile and pain management literature findings for the following NMDA receptor antagonists: ketamine, memantine, dextromethorphan, and magnesium. The literature on this topic is characterized by small studies, many of which exhibit methodological flaws. To date, ketamine is the most studied NMDA receptor antagonist for both acute and chronic pain management. Although further research about NMDA receptor antagonists for analgesia is needed and the optimal dosage/administration regimens for these drugs have yet to be determined, ketamine appears to hold the most promise and may be of particular value in the perioperative pain management realm.
- 27 March 2017
- Published by Springer Nature in Journal of Anesthesia
- Vol. 31 (3) , 424-431
Prevention of chronic post-surgical pain: the importance of early identification of risk factors
Chronic post-surgical pain (CPSP) is currently an inevitable surgical complication. Despite the advances in surgical techniques and the development of new modalities for pain management, CPSP can affect 15–60% of all surgical patients. The development of chronic pain represents a burden to both the patient and to the community. In order to have a meaningful impact on this debilitating condition it is essential to identify those at risk. Early identification of patients at risk will help to reduce the percentage of patients who go on to develop CPSP. Unfortunately, evidence about any effective actions to reduce this condition is limited. This review will focus on providing context to the challenging problem of CPSP. The possible role of both the surgeon and anesthesiologist in reducing the incidence of this problem will be explored.
- 27 March 2017
- Published by Springer Nature in Journal of Anesthesia
- Vol. 31 (3) , 424-431
Prevention of chronic post-surgical pain: the importance of early identification of risk factors
Chronic post-surgical pain (CPSP) is currently an inevitable surgical complication. Despite the advances in surgical techniques and the development of new modalities for pain management, CPSP can affect 15–60% of all surgical patients. The development of chronic pain represents a burden to both the patient and to the community. In order to have a meaningful impact on this debilitating condition it is essential to identify those at risk. Early identification of patients at risk will help to reduce the percentage of patients who go on to develop CPSP. Unfortunately, evidence about any effective actions to reduce this condition is limited. This review will focus on providing context to the challenging problem of CPSP. The possible role of both the surgeon and anesthesiologist in reducing the incidence of this problem will be explored.
- Open Access
- 1 January 2015
- Published by Medknow in Journal of Anaesthesiology Clinical Pharmacology
- Vol. 31 (1) , 6-13
Postoperative pain management in patients with chronic kidney disease
Chronic kidney disease (CKD) is a health care problem with increasing prevalence worldwide. Pain management represents one of the challenges in providing perioperative care for this group of patients. Physicians from different specialties may be involved in pain management of CKD patients, especially in advanced stages. It is important to understand the clinical staging of kidney function in CKD patients as the pharmacotherapeutic pain management strategies change as kidney function becomes progressively impaired. Special emphasis should be placed on dose adjustment of certain analgesics as well as prevention of further deterioration of renal function that could be induced by certain classes of analgesics. Chronic pain is a common finding in CKD patients which may be caused by the primary disease that led to kidney damage or can be a direct result of CKD and hemodialysis. The presence of chronic pain in some of the CKD patients makes postoperative pain management in these patients more challenging. This review focuses on the plans and challenges of postoperative pain management for patient at different stages of CKD undergoing surgical intervention to provide optimum pain control for this patient population. Further clinical studies are required to address the optimal medication regimen for postoperative pain management in the different stages of CKD.
- 1 January 2015
- Published by Medknow in Journal of Anaesthesiology Clinical Pharmacology
- Vol. 31 (1) , 6-13
Open AccessPostoperative pain management in patients with chronic kidney disease
Chronic kidney disease (CKD) is a health care problem with increasing prevalence worldwide. Pain management represents one of the challenges in providing perioperative care for this group of patients. Physicians from different specialties may be involved in pain management of CKD patients, especially in advanced stages. It is important to understand the clinical staging of kidney function in CKD patients as the pharmacotherapeutic pain management strategies change as kidney function becomes progressively impaired. Special emphasis should be placed on dose adjustment of certain analgesics as well as prevention of further deterioration of renal function that could be induced by certain classes of analgesics. Chronic pain is a common finding in CKD patients which may be caused by the primary disease that led to kidney damage or can be a direct result of CKD and hemodialysis. The presence of chronic pain in some of the CKD patients makes postoperative pain management in these patients more challenging. This review focuses on the plans and challenges of postoperative pain management for patient at different stages of CKD undergoing surgical intervention to provide optimum pain control for this patient population. Further clinical studies are required to address the optimal medication regimen for postoperative pain management in the different stages of CKD.
- 1 October 2013
- Published by Wiley in Pediatric Anesthesia
- Vol. 23 (11) , 1104-1105
Sickle cell pain management: are we missing the role of pronociception and neuropathic pain?
- 1 October 2013
- Published by Wiley in Pediatric Anesthesia
- Vol. 23 (11) , 1104-1105
Sickle cell pain management: are we missing the role of pronociception and neuropathic pain?
- Open Access
- 27 February 2013
- Published by Sultan Qaboos University in Sultan Qaboos University Medical Journal
- Vol. 13 (1) , 185-187
The Dilemma of Opioid-Induced Hyperalgesia and Tolerance in Chronic Opioid Therapy
By Qutaiba Amir Tawfic, Ali S. Faris, and Rohit R. Date, Published on 02/27/13
- 27 February 2013
- Published by Sultan Qaboos University in Sultan Qaboos University Medical Journal
- Vol. 13 (1) , 185-187
Open AccessThe Dilemma of Opioid-Induced Hyperalgesia and Tolerance in Chronic Opioid Therapy
By Qutaiba Amir Tawfic, Ali S. Faris, and Rohit R. Date, Published on 02/27/13
- Open Access
- 4 September 2012
- Published by Sultan Qaboos University in Sultan Qaboos University Medical Journal
- Vol. 12 (2) , 177-183
Adult Sickle Cell Disease : A Five-year Experience of Intensive Care Management in a University Hospital in Oman
Objectives: Sickle cell disease (SCD) is an inherited disease caused by an abnormal type of haemoglobin. It is one of the most common genetic blood disorders in the Gulf area, including Oman. It may be associated with complications requiring intensive care unit (ICU) admission. This study investigated the causes of ICU admission for SCD patients. Methods: This was a retrospective analysis of all adult patients ≥12 years old with SCD admitted to Sultan Qaboos University Hospital (SQUH) ICU between 1st January 2005 and 31st December 2009. Results: A total number of 49 sickle cell patients were admitted 56 times to ICU. The reasons for admission were acute chest syndrome (69.6%), painful crises (16.1%), multi-organ failure (7.1%) and others (7.2%). The mortality for SCD patients in our ICU was 16.1%. The haemoglobin (Hb) and Hb S levels at time of ICU admission were studied as predictors of mortality and neither showed statistical significance by Student’s t-test. The odds ratio, with 95% confidence intervals, was used to study other six organ supportive measures as predictors of mortality. The need for inotropic support and mechanical ventilation was a good predictor of mortality. While the need for non-invasive ventilation, haemofiltration, blood transfusions and exchange transfusions were not significant predictors of mortality. Conclusion: Acute chest syndrome is the main cause of ICU admission in SCD patient. Unlike other supportive measures, the use of inotropic support and/or mechanical ventilation is an indicator of high mortality rate SCD patient.
- 4 September 2012
- Published by Sultan Qaboos University in Sultan Qaboos University Medical Journal
- Vol. 12 (2) , 177-183
Open AccessAdult Sickle Cell Disease : A Five-year Experience of Intensive Care Management in a University Hospital in Oman
Objectives: Sickle cell disease (SCD) is an inherited disease caused by an abnormal type of haemoglobin. It is one of the most common genetic blood disorders in the Gulf area, including Oman. It may be associated with complications requiring intensive care unit (ICU) admission. This study investigated the causes of ICU admission for SCD patients. Methods: This was a retrospective analysis of all adult patients ≥12 years old with SCD admitted to Sultan Qaboos University Hospital (SQUH) ICU between 1st January 2005 and 31st December 2009. Results: A total number of 49 sickle cell patients were admitted 56 times to ICU. The reasons for admission were acute chest syndrome (69.6%), painful crises (16.1%), multi-organ failure (7.1%) and others (7.2%). The mortality for SCD patients in our ICU was 16.1%. The haemoglobin (Hb) and Hb S levels at time of ICU admission were studied as predictors of mortality and neither showed statistical significance by Student’s t-test. The odds ratio, with 95% confidence intervals, was used to study other six organ supportive measures as predictors of mortality. The need for inotropic support and mechanical ventilation was a good predictor of mortality. While the need for non-invasive ventilation, haemofiltration, blood transfusions and exchange transfusions were not significant predictors of mortality. Conclusion: Acute chest syndrome is the main cause of ICU admission in SCD patient. Unlike other supportive measures, the use of inotropic support and/or mechanical ventilation is an indicator of high mortality rate SCD patient.
- Open Access
- 16 May 2012
- Published by Oman Medical Journal in Oman Medical Journal
- Vol. 27 (3) , 254-255
Prevention of Intra-operative Cerebral Ischemia during Carotid Endarterectomy, Loco-regional versus General Anesthesia
Carotid endarterectomy (CEA), as a prophylactic operation is becoming more popular. It is performed in patients who are at risk of stroke from dislodged atheromatous plaque at the carotid bifurcation. The major concern during CEA is the detection of cerebral hypoperfusion or ischemia during carotid cross clamping. Some studies have shown that the introduction of loco-regional anesthesia has lowered the incidence of major complications compared with general anesthesia since ischemia detection is easier in conscious patient.
- 16 May 2012
- Published by Oman Medical Journal in Oman Medical Journal
- Vol. 27 (3) , 254-255
Open AccessPrevention of Intra-operative Cerebral Ischemia during Carotid Endarterectomy, Loco-regional versus General Anesthesia
Carotid endarterectomy (CEA), as a prophylactic operation is becoming more popular. It is performed in patients who are at risk of stroke from dislodged atheromatous plaque at the carotid bifurcation. The major concern during CEA is the detection of cerebral hypoperfusion or ischemia during carotid cross clamping. Some studies have shown that the introduction of loco-regional anesthesia has lowered the incidence of major complications compared with general anesthesia since ischemia detection is easier in conscious patient.
- Open Access
- 25 October 2011
- Published by Sultan Qaboos University in Sultan Qaboos University Medical Journal
- Vol. 11 (4) , 527-528
GlideScope® for Assessment of Recurrent Laryngeal Nerve Integrity after Thyroid Surgery
By Qutaiba A. Tawfic, Pradipta Bhakta, Pragyandipta Mishra, et al., Published on 10/25/11
- 25 October 2011
- Published by Sultan Qaboos University in Sultan Qaboos University Medical Journal
- Vol. 11 (4) , 527-528
Open AccessGlideScope® for Assessment of Recurrent Laryngeal Nerve Integrity after Thyroid Surgery
By Qutaiba A. Tawfic, Pradipta Bhakta, Pragyandipta Mishra, et al., Published on 10/25/11